Stereotactic Ablative Body Radiation Therapy (SABR) to Lymph Node Oligometastases: UK Experience and Clinical Outcome

被引:1
|
作者
Goldsmith, C. S. [1 ]
Gaya, A. [1 ]
Plowman, N. [1 ]
机构
[1] Harley St Clin, London, England
关键词
D O I
10.1016/j.ijrobp.2013.06.470
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S182 / S182
页数:1
相关论文
共 50 条
  • [1] Initial Outcomes From a Single Institution Experience With Stereotactic Ablative Radiation Therapy (SABR) for Oligometastases
    Dagan, R.
    Yeung, A. R.
    Zlotecki, R. A.
    Morris, C. G.
    Okunieff, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S182 - S183
  • [2] Stereotactic Body Radiation Therapy (SBRT) in Pelvic Lymph Node Oligometastases
    Reshko, Leonid B.
    Richardson, Martin K.
    Spencer, Kelly
    Kersh, Charles R.
    CANCER INVESTIGATION, 2020, 38 (10) : 599 - 607
  • [3] Stereotactic Body Radiation Therapy (SBRT) in Pelvic Lymph Node Oligometastases
    Reshko, L. B.
    Richardson, K. M.
    Spencer, K. M.
    Kersh, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E571 - E572
  • [4] Stereotactic ablative body radiation therapy (SABR) in NSW
    Elizabeth R. Claridge Mackonis
    Nicholas Hardcastle
    Annette Haworth
    Physical and Engineering Sciences in Medicine, 2020, 43 : 641 - 650
  • [5] Stereotactic ablative body radiation therapy (SABR) in NSW
    Mackonis, Elizabeth R. Claridge
    Hardcastle, Nicholas
    Haworth, Annette
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2020, 43 (02) : 641 - 650
  • [6] Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases
    A. J. Conde-Moreno
    J. L. Lopez-Guerra
    V. A. Macias
    M. L. Vázquez de la Torre
    P. Samper Ots
    S. San José-Maderuelo
    J. Pastor Peidro
    J. López-Torrecilla
    J. Expósito-Hernández
    Clinical and Translational Oncology, 2016, 18 : 342 - 351
  • [7] Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases
    Conde-Moreno, A. J.
    Lopez-Guerra, J. L.
    Macias, V. A.
    Vazquez de la Torre, M. L.
    Samper Ots, P.
    San Jose-Maderuelo, S.
    Pastor Peidro, J.
    Lopez-Torrecilla, J.
    Exposito-Hernandez, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (04): : 342 - 351
  • [8] Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT)
    Folkert, Michael R.
    Timmerman, Robert D.
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 109 : 3 - 14
  • [9] Outcomes of Stereotactic Ablative Radiotherapy for Lymph Node Oligometastases
    Zhao, Y.
    Yeung, R.
    Beaton, L. E.
    Liu, M.
    Olson, R. A.
    Schellenberg, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E574 - E575
  • [10] OUTCOMES OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR LYMPH NODE OLIGOMETASTASES
    Zhao, Yizhou
    Yeung, Rosanna
    Beaton, Laura
    Liu, Mitchell
    Olson, Robert
    Schellenberg, Devin
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S95 - S95